U.S. Senator Al Franken asked federal regulators and Medtronic Inc for detailed information about injuries associated with the company’s bone graft Infuse following a newspaper report that Medtronic hid thousands of adverse events linked to the product. The Minneapolis Star Tribune reported on Sunday that Medtronic studied the outcomes of 3,600 patients who received Infuse […]
Redefines data-driven marketing services for the life sciences industry; partnership with Medikly further expands the network’s insight-driven client offerings
U.S. federal health regulators have proposed banning Theranos Inc founder Elizabeth Holmes from the blood-testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory, the Wall Street Journal reported on Wednesday. The Centers for Medicare and Medicaid (CMS) said in letter dated March 18 that […]
Even during a humanitarian crisis, treating mental illnesses is not an optional luxury, experts said before a World Bank/World Health Organization meeting on the issue in Washington.
A $250 million grant from Silicon Valley billionaire Sean Parker aims to speed development of more effective cancer treatments by fostering collaboration among leading researchers.
A total of 202 people have been detained in connection with a scandal over an illegal black market vaccine ring, the Chinese government said on Wednesday, as it vowed to improve supervision of the market. The case, involving millions of illegal trades of vaccines through a black market drugs ring, has ignited public ire and […]
San Francisco-based Medivation has reportedly rejected a bid by Paris-based Sanofi.
Valeant’s shares fell after the company received a notice of default over failure to file its 10-k form.
U.S. lawmakers on Tuesday approved a bill to provide financial incentives to companies developing treatments for the Zika virus, and the White House said President Barack Obama was expected to sign the legislation although it is insufficient to meet the challenge. The measure allows the Food and Drug Administration to include Zika drug developers in […]
An independent panel of experts advising the U.S. Food and Drug Administration recommended that Clovis Oncology Inc’s lung cancer drug not be approved based on existing trial data. The panel voted 12-1 against giving the drug an accelerated approval, and recommended the FDA wait for the results from an ongoing late-stage trial that compares the […]
The Centers for Medicare and Medicaid Services has been letting patients grade their hospital experiences, and those “patient experience scores” may give some insight into a hospital’s health outcomes, a new study suggests. Some people have been concerned that patient experience isn’t the most important factor to measure, said coauthor Dr. Ashish K. Jha of […]
A federal appeals court revived a long-running lawsuit accusing Pfizer Inc. of misleading investors about the safety of the company’s Celebrex and Bextra pain-relieving drugs.
Indian drugmakers give up a battle to copy drugs developed by Bristol-Myers Squibb and AstraZeneca, blaming lack of government support for cheap generics and Big Pharma pressure.
Bayer might look into selling its animal health division if it continues to struggle to find takeover targets for the business, the German drugmaker’s incoming chief executive said.
April 12, 2016By Alex Keown, BioSpace.com Breaking News Staff PALO ALTO, Calif. – Expect Gilead Sciences (GILD) to be more aggressive in M&A activity following its $1.2 billion deal to snap up Cambridge, Mass.-based Nimbus Apollo, Inc. earlier this month. That’s the message from analysts at Kenra Investors, which has taken a long-term stake […]
Top health officials expressed heightened concern on Monday about the threat posed to the United States by the Zika virus, saying the mosquito that spreads it is now present in about 30 states and hundreds of thousands of infections could appear in Puerto Rico. At a White House briefing, they stepped up pressure on the […]
Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 11, 2016 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Intellia Therapeutics, Inc. announced today a licensing and collaboration agreement to advance CRISPR/Cas gene-editing technology for in vivo therapeutic development. In addition to the discovery, development and commercialization of new therapies, the companies will focus on technology development of […]
U.S. adults who sleep no more than five hours per night or who have a diagnosed sleep disorder are more likely to have suffered a recent cold than those who sleep more.
Valeant Pharmaceuticals International Inc. said it had asked outgoing CEO Michael Pearson to cooperate with the U.S. Senate Committee on Aging after he failed to show up at a hearing.
Verily, formerly Google Life Sciences, is coming under fire for how its CEO approaches business, including some raised eyebrows over a research contract.